SoftWave Shockwave Therapy is a non-invasive, electrohydraulic treatment designed to accelerate healing and promote tissue repair in a wide range of foot and ankle conditions. This advanced therapy utilizes deep tissue propagation to deliver targeted shockwaves, stimulating circulation and cell regeneration. It is a highly effective treatment option for conditions like plantar fasciitis, Achilles tendinopathy, diabetic foot ulcers, Morton’s neuroma, peripheral neuropathy, chronic wounds, heel spurs, and bunion pain.

One of the key benefits of SoftWave Shockwave Therapy is its convenience. Patients can experience quick sessions with minimal discomfort, making it a practical choice for those with busy schedules. It also serves as a safer alternative to opioids and cortisone shots, helping to minimize risks and reduce patient anxiety associated with more invasive treatments. The device is easy to use and provides a versatile solution for both pain relief and wound healing.

FDA cleared and Health Canada licensed, SoftWave Shockwave Therapy is a cost-effective option compared to more expensive treatments like hyperbaric oxygen therapy, HBOT, and negative pressure wound therapy, NPWT. With its ability to enhance practice efficiency and improve patient outcomes, this therapy has become a valuable tool in modern podiatry practices.